6 assets in Pancreas Disorder

Therapeutic assets addressing Pancreas Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
nhs7108 Pancreas Disorder	Aimmune Nestlé Health Science US R&D, LLC	P2	CCC (53)
Pancrelipase Pancreas Disorder	Aimmune Nestlé Health Science US R&D, LLC	P2	CCC (53)
Kras-Specific Autologous Tcr-T Cell Pancreas Disorder	Corregene Biotechnology Co., Ltd	P1	CC (43)
Lacosamide Pancreas Disorder	Indiana University	P1	CC (43)
Clostridium Butyricum Miyairi 588 Pancreas Disorder	Casa di Cura Dott. Pederzoli	N/A	D (30)